期刊文献+

消增1号治疗胃上皮异型增生49例临床观察 被引量:1

Clinical Observation on “Xiaozeng No.1” for 49 Cases of Gastric Epithelial Dysplasia
原文传递
导出
摘要 目的:观察消增1号治疗胃上皮异型增生的临床疗效。方法:将97例胃上皮异型增生患者随机分为治疗组49例和对照组48例。治疗组予消增1号,对照组予泮托拉唑钠肠溶胶囊和膜固思达片治疗,疗程为3个月。观察两组治疗前后的主要临床症状及异型增生变化情况。结果:①治疗后,对照组患者的胃痞、胃痛、泛酸、嗳气、嘈杂和胃胀症状明显改善(P<0.05,P<0.01),治疗组患者的胃痞、胃痛、泛酸、嗳气、嘈杂、胃胀、乏力和纳差症状亦明显改善(P<0.05,P<0.01),且治疗组胃痞、胃痛、泛酸、嗳气、乏力和纳差症状的改善优于对照组(P<0.01)。②治疗后,两组患者异型增生的情况均显著改善(P<0.05,P<0.01),且治疗组较对照组改善更加明显(P<0.01)。③治疗后,治疗组和对照组异型增生改善的有效率分别为85.7%和29.2%,治疗组优于对照组(P<0.01)。结论:消增1号能有效逆转胃上皮异型增生,改善患者的临床症状。 Objective : To observe the clinical efficacy of “Xiaozeng No. 1” in treating gastric epithelial dysplasia (GED). Methods: Ninety-seven patients with GED were randomly divided into two groups: the treatment group in which forty-nine patients were treated by “Xiaozeng No. 1 ” and the control group in which forty-eight patients were treated by pantoprazole sodium enteric-coated capsule and rebamipide tablet, with the course of three months. The main clinical symptoms and the epithelial dysplasia were observed before and after treatment. Results: ①After treatment, the symptoms such as gastralgia, acid regurgitation, belch, epigastric upset and gastrectasia in control group obviously improved (P 〈 0.05, P 〈 0.01 ), the symptoms such as gastralgia, acid regurgitation, belch, epigastric upset, gastrectasia, astbenia and poor appetite in treatment group also improved (P 〈 0.05, P 〈 0.01 ), and the improvement of the symptoms including gastralgia, acid regurgitation, belch, asthenia and poor appetite in treatment group was better than that in control group (P 〈0.01 ). ②Afler treatment, the epithelial dysplasia in both groups significantly improved (P 〈0.05 ,P 〈0.01 ) , and the effect of treatment group was better than that of control group (P 〈0.01 ). ③After treatment, the effective rates of treatment group and control group on dysplasia improvement were 85.7% and 29.2% respectively, and the effect of treatment group was better than thai of control group (P 〈0.01 ). Conclusion: “Xiaozeng No. 1” can effectively reverse the gastric epithelial dysplasia and improve the clinical symptoms.
出处 《上海中医药大学学报》 CAS 2013年第1期26-29,共4页 Academic Journal of Shanghai University of Traditional Chinese Medicine
基金 上海中医药大学附属普陀医院科研项目(2011L041)
关键词 胃上皮异型增生 消增1号 中医药治疗 Gastric epithelial dysplasia “Xiaozeng No. 1 ” traditional Chinese medical therapy
  • 相关文献

参考文献9

二级参考文献129

共引文献2456

同被引文献13

引证文献1

二级引证文献4

  • 1中华中医药学会脾胃病分会,中华医学会消化病学分会消化肿瘤协作组,中华医学会消化内镜学分会早癌协作组,中华医学会病理学分会消化病理学组,中国中西医结合学会消化系统疾病专业委员会,王萍,李鹏,陈萦晅,李理,卢瑗瑗,周炜洵,卞立群,张北华,尹晓岚,李军祥,陈杰,张澍田,时永全,唐旭东.中国整合胃癌前病变临床管理指南[J].胃肠病学,2021,26(2):91-111. 被引量:70
  • 2中华中医药学会脾胃病分会,中华医学会消化病学分会消化肿瘤协作组,中华医学会消化内镜学分会早癌协作组,中华医学会病理学分会消化病理学组,中国中西医结合学会消化系统疾病专业委员会,唐旭东,时永全,张澍田,陈杰,李军祥,王萍,李鹏,陈萦晅,李理,卢瑗瑗,周炜洵,卞立群,张北华,尹晓岚.中国整合胃癌前病变临床管理指南[J].中国中西医结合消化杂志,2022,30(3):163-183. 被引量:77
  • 3谢秋雨,姚柱豪,骆云丰.骆云丰论治胃低级别上皮内瘤变经验[J].科学咨询,2023(7):145-147.
  • 4辛茜,左静,吕书勤.胃癌前病变中西医研究进展[J].临床医学进展,2023,13(5):7251-7256.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部